

HGH Fragment 176-191
HGH Fragment 176-191 is the unmodified C-terminal segment of the human growth hormone sequence, corresponding to amino acids 176 through 191.
It is used in laboratory research as the parent fragment for comparison against modified analogs, particularly in adipocyte and lipid-metabolism models where investigators are attempting to attribute observed activity to a specific region of the hormone sequence.
- Compound class
- Synthetic research compound
- Research category
- GLP-1 & Metabolic
- SKU
- NVR-HGH-FRAGMENT-176-191-5MG
- Appearance
- Lyophilized powder
- Storage
- Store lyophilized at −20 °C. Protect from light and moisture.
For research use only — not for human or animal consumption.
Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.
More detail on HGH Fragment 176-191.
Analytical values reflect per-lot documentation and appear once a batch is released.
Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.
HGH Fragment 176-191 is supplied for in vitro laboratory research. Batch-specific analytical documentation is provided when available for the released lot.
Related research materials


Cagrilintide
10 mg
Long-acting amylin analog studied for amylin and calcitonin receptor signaling in laboratory models.

Cagrilintide / Semaglutide
5/5 mg
Research blend pairing an amylin analog with a GLP-1 receptor agonist for combined-pathway studies.

Retatrutide
4 strengths available
Triple agonist peptide targeting GIP, GLP-1, and glucagon receptors in preclinical metabolic research.
Up to 64% lower per mg